Mechanisms of the selective cytotoxic actions of certain essential fatty acids

Advances in Experimental Medicine and Biology

Volumn 400, Issue A, 1997, Pages 539-544

  Cantrill, Richard C ^a   Ells, G W ^a   DeMarco, A C ^a   Horrobin, D F ^a  

^a Efamol Limited   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ESSENTIAL FATTY ACID; POLYUNSATURATED FATTY ACID;

CELL DEATH; CONFERENCE PAPER; FATTY ACID METABOLISM; ICOSANOID METABOLISM; LIPID PEROXIDATION; LONG TERM POTENTIATION; MEMBRANE FLUIDITY; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE; CELL SURVIVAL; CYTOTOXINS; FATTY ACIDS, ESSENTIAL; HUMANS; IRON; LIPID PEROXIDATION; MEMBRANE FLUIDITY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR CELLS, CULTURED; VITAMIN E;

EID: 0031420970     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5325-0_73     Document Type: Article

References (17)

1. Bégin M.E., Ells, G., Das, U.N. and Horrobin, D.F. J. Natl. Cancer Inst. 77:1053-1062, 1986.
2. Cantrill, R.C., Davidson, B.C., Katzeff, I.K. and Booyens, J. Prog. Lipid. Res. 25:547-550, 1986.
3. Fujiwara, F., Todo, S. and Imashuku, S. Prostaglandins Leukotr. Med. 23:311-320, 1986.
4. Chow, S.C., Sisfontes, L., Björkhem, I. and Jondal, M. Lipids 24:700-704, 1989.
5. Horrobin, D.F. In: Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine (D.F. Horrobin, ed.) Wiley-Liss, New York, 1990, pp. 351-377.
6. Bégin, M.E., Ells, G. and Horrobin, D.F. J. Natl. Cancer Inst. 80:188-194, 1988.
7. Cantrill, R.C., Ells, G.W., Chisholm, K. and Horrobin D.F. Cancer Letts. (in press) 1993.
8. Spector, A.A., North, J.A., Buettner, G.R. and Cornelius, A.S. ISFAL Meeting, Lugano, Switzerland, Abstract pp. 73, 1993.
9. Takeda, S., Sim, P.G., Horrobin, D.F., Chisholm, K.A., Simmons, V.A., Ells, G.W., Jenkins, G.K. and Morse-Fisher, N.L. Int. J. Oncol. 1:759-763, 1992.
10. Cantrill, R.C., Ells, G.W., Elliot, M.L. and Horrobin, D.F. In: Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury (S. Nigam, K.V. Honn, L.J. Marnett, and T.L. Walden, Jr., eds.) Kluwer, Boston, 1993. pp. 555-558.
11. Cantrill, R.C., Ells, G.W., Chisholm, K.A., Hughes, B.J. and Horrobin, D.F. Anticancer Res. (in press), 1993.
12. DeAntueno, R.J., Cantrill, R.C., Elis, G.W., Elliot, M., Huang, Y.-S. and Horrobin, D.F. Anticancer Res. 13:973-978, 1993.
13. Cantrill, R.C., Huang, Y.-S., Ells, G.W. and Horrobin, D.F. Lipids 28:163-166, 1993.
14. Cornelius, A.S., Yerram, N.R., Kratz, D.A. and Spector, A.A. Cancer Res. 51:6025-6030, 1991.
15. Cohen, L.A., Chen-Backlund, J.-Y., Sepkovic, D.W. and Sugie, S. Lipids 28:449-456, 1993.
16. Gonzales, M.J., Schemmel, R.A., Gray, J.I., Dugan, L. Jr., Sheffield, L.G. and Welsch, C.W. Carcinogenesis 12:1231-1235, 1991.
17. Fearon, H.C.H., Falconer, J.S., Ross, J.A. and Carter, D.C. ISFAL Meeting, Lugano, Switzerland, Abstract pp. 73, 1993.